Publications for all Oxford Principal Investigators within the CAMS Oxford Institute are included here, please use the search functions for publications related to specific Principal Investigators.
Pleural fluid proteomics from patients with pleural infection shows signatures of diverse neutrophilic responses: The Oxford Pleural Infection Endotyping Study (TORPIDS-2).
Kanellakis NI. et al, (2025), Eur Respir J
Bedside to bench and back again-translational research in interventional pulmonology.
Iqbal B. et al, (2024), Current opinion in pulmonary medicine
PneumoLLM: Harnessing the power of large language model for pneumoconiosis diagnosis.
Song M. et al, (2024), Medical image analysis, 97
Unconventional human CD61 pairing with CD103 promotes TCR signaling and antigen-specific T cell cytotoxicity
Hamid MHBA. et al, (2024), Nature Immunology, 25, 834 - 846
Clinical identification of malignant pleural effusions.
Jia J. et al, (2023), Translational oncology, 39
Early Video Assisted Thoracoscopic Surgery (VATS) or Intrapleural Enzyme Therapy (IET) in Pleural Infection - A Feasibility Randomized Controlled Trial (The Third Multicenter Intrapleural Sepsis Trial - MIST-3).
Bedawi EO. et al, (2023), American journal of respiratory and critical care medicine
Achieving Molecular Profiling in Pleural Biopsies
Sundaralingam A. et al, (2023), Chest, 163, 1328 - 1339
Biological effect of tissue plasminogen activator (t-PA) and DNase intrapleural delivery in pleural infection patients
Kanellakis NI. et al, (2019), BMJ Open Respiratory Research, 6, e000440 - e000440
Patient derived pleural mesothelioma cell lines, can be used as tools, to guide patient stratification
Kanellakis NI. et al, (2019), EUROPEAN RESPIRATORY JOURNAL, 54
A Pilot Feasibility Study in Establishing the Role of Ultrasound-Guided Pleural Biopsies in Pleural Infection (The AUDIO Study)
Psallidas I. et al, (2018), Chest, 154, 766 - 772
Development and validation of response markers to predict survival and pleurodesis success in patients with malignant pleural effusion (PROMISE): a multicohort analysis
Psallidas I. et al, (2018), The Lancet Oncology, 19, 930 - 939
Survival And Pleurodesis Response Markers In Malignant Pleural Effusion-The Promise Study
Psallidas I. et al, (2018), AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 197
BIOLOGICAL MARKERS OF FAVOURABLE PROGNOSIS AND SUCCESSFUL PLEURODESIS FOR MALIGNANT PLEURAL EFFUSION
Psallidas I. et al, (2016), THORAX, 71, A54 - A55
Biological markers of successful pleurodesis for malignant pleural effusion
Psallidas I. et al, (2016), 11.2 Pleural and Mediastinal Malignancies